Bailey Fisher is delighted to have worked with Metrasens Ltd on the search for a Non Executive Director, resulting in the successful appointment of US-based sensor technology expert, Bret Bader.
Metrasens is a VC and PE backed company specialising in developing, marketing, and installing medical devices that improve safety in hospitals. The company provides a ferromagnetic detection system that alerts staff to the presence of ferromagnetic objects before they are inadvertently taken into the MRI suite; and a device to locate metallic objects within a patient. Founded in 2005, Metrasens is based in Malvern, UK, with an office in the US.
The successful candidate, Bret Bader, is currently CEO of Owlstone, a US company developing and manufacturing proprietary chemical detection technology. Previously, he was General Manager and Vice President: The Americas at Smiths Detection, the world leading manufacturer of security screening sensors for the detection of explosives, narcotics, weapons and chemical and biological warfare agents.